Arax Advisory Partners’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Arax Advisory Partners’s Portfolio CDC Stock Details CDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.8K	Buy	+482	New	+$35.1K	﹤0.01%	3541

Other funds holding CDC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return

AFW

Atlantic Family Wealth Coral Gables, Florida $156M AUM 21.68% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

Arax Advisory Partners's CDC Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) in Q2 2026: 482 shares worth $35.8K. The stake represents ﹤0.01% of the portfolio and ranks #3541 among its holdings.

101 funds tracked by Wall St. Rank hold CDC as of Q2 2026.

Arax Advisory Partners held 482 shares of VictoryShares US EQ Income Enhanced Volatility Wtd ETF worth $35.8K as of Q2 2026.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF was a new Arax Advisory Partners position in Q2 2026.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3541 holding.
101 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.